Vaccine News and Research

Latest Vaccine News and Research

New discovery could help efforts to produce more effective vaccines

The best defense is a good offense, especially when it comes to the immune system. The troops that respond to an infection are split into two squadrons, and, until recently, it seemed that the two were independent, without much interaction.

9 Sep 2014

FDA approves use of Menactra for booster vaccination against meningococcal disease

Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration approved use of Menactra® [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] for booster vaccination against meningococcal disease in persons 15 years through 55 years of age.

9 Sep 2014

Cholera against cholera: an interview with Dr Bruce Turnbull, University of Leeds

Cholera bacteria, and other types of bacteria that cause diarrheal diseases, infect your intestines where they release AB5 protein toxins – that is they have a single toxic A-subunit that is linked to a pentamer of B-subunits that act as the delivery vehicle to transport the A-subunit into the cells.

8 Sep 2014

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries.

8 Sep 2014

New breast cancer vaccine provides evidence of immunotherapy in preventing disease recurrence

A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is combined with a powerful immunotherapy drug.

8 Sep 2014

Hospitals can improve flu vaccination rate among health care workers by using mandatory policy

Hospitals can greatly improve their flu vaccination rate among health care workers by using a mandatory employee vaccination policy, according to a Henry Ford Health System study.

8 Sep 2014

Scientists identify how immune cells use two critical receptors to clear dead cells from the body

In most of the tissues of the body, specialized immune cells are entrusted with the task of engulfing the billions of dead cells that are generated every day.

8 Sep 2014

Viewpoints: End-of-life discussions; seniors missing their vaccinations; health law's new political calculations

There is reason to hope that a degree of sanity may be returning to the touchy issue of advance planning for medical care at the end of life.

8 Sep 2014

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin).

8 Sep 2014

61% less cases of genital warts among women after introducing HPV vaccination program

GPs in Australia are managing 61 per cent less cases of genital warts among young women since the introduction of the national human papillomavirus (HPV) vaccination program, a new study from the University of Sydney reveals.

8 Sep 2014

Peramivir drug safe, effective at alleviating influenza symptoms

An analysis of phase 2 and phase 3 clinical trials shows that a single injected dose of the neuraminidase inhibitor (NAI) peramivir is safe and effective at alleviating influenza symptoms, including fever and viral shedding, when administered within 48 hours of the onset of symptoms.

6 Sep 2014

Study compares breast and bottle fed infants

Infant rhesus monkeys receiving different diets early in life develop distinct immune systems that persist months after weaning, a study by researchers from UC Davis, the California National Primate Research Center (CNPRC) at UC Davis and UC San Francisco have shown.

5 Sep 2014

Avian influenza A H3N8 virus poses threat to humans

A study led by St. Jude Children's Research Hospital scientists found the avian influenza A H3N8 virus that killed harbor seals along the New England coast can spread through respiratory droplets and poses a threat to humans.

5 Sep 2014

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, has released an update on the clinical trial pipeline for its lead immunotherapy products treating basal cell carcinoma (BCC) and breast cancer.

4 Sep 2014

New antibody in HIV-infected person binds to virus

An NIH-led team of scientists has discovered a new vulnerability in the armor of HIV that a vaccine, other preventive regimen or treatment could exploit.

4 Sep 2014

Legatum Foundation donates $150,000 to Ebola Crisis Fund

The Legatum Foundation, the development arm of the Legatum Group, today announced a donation of $150,000 to the Ebola Crisis Fund, a fund established to help prevent the spread of the deadly Ebola virus in West Africa.

3 Sep 2014

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today promising preliminary results from a preclinical study with its ricin toxin vaccine RiVax™, in a non-human primate (NHP) lethal aerosol exposure model.

2 Sep 2014

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

Cepheid announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection.

2 Sep 2014

New vaccine in bid to move away from needles and syringes to skin delivery procedures

Drug delivery technologies that improve access and overall efficacy are becoming an essential part of the entire drug development process.

2 Sep 2014

‘Concerning’ rise in pneumococcus risk factors

Researchers report that the incidence of Streptococcus pneumoniae infection has fallen significantly in the USA in the past decade but describe a “concerning trend” whereby the baseline health status of those with serious pneumococcal disease has worsened.

1 Sep 2014

Vaccine News and Research

Latest Vaccine News and Research

New discovery could help efforts to produce more effective vaccines

FDA approves use of Menactra for booster vaccination against meningococcal disease

Cholera against cholera: an interview with Dr Bruce Turnbull, University of Leeds

Canada funds 22 inventive ideas for improving health in low-resource countries

New breast cancer vaccine provides evidence of immunotherapy in preventing disease recurrence

Hospitals can improve flu vaccination rate among health care workers by using mandatory policy

Scientists identify how immune cells use two critical receptors to clear dead cells from the body

Viewpoints: End-of-life discussions; seniors missing their vaccinations; health law's new political calculations

Soligenix acquires novel orphan drug candidate for treatment of CTCL

61% less cases of genital warts among women after introducing HPV vaccination program

Peramivir drug safe, effective at alleviating influenza symptoms

Study compares breast and bottle fed infants

Avian influenza A H3N8 virus poses threat to humans

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

New antibody in HIV-infected person binds to virus

Legatum Foundation donates $150,000 to Ebola Crisis Fund

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

New vaccine in bid to move away from needles and syringes to skin delivery procedures

‘Concerning’ rise in pneumococcus risk factors

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in